Sign in

CIK 0001422143

  • Non-accelerated filer
  • Smaller reporting company

Kura Oncology, Inc.

Sign in to watch
Ticker
KURA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
611547851
Phone
+1 858-500-8800
Business address
4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
Former names
ZETA ACQUISITION CORP III
Open-market buys, last 90 days
$4,248,530
in 3 filings
Open-market sales, last 90 days
$1,310,361
in 7 filings, $252K under 10b5-1 plans

Net +$2,938,169. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 38 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-04 Malley Thomas Director Grant or award · Option to purchase common stock +35,000 35,000
2026-03-18 Malley Thomas Director Exercise or conversion +10,000 $3.12 $31K 10,000
2026-03-18 Malley Thomas Director Exercise or conversion · Stock Option (Right to Buy) +10,000 0
2025-06-05 Malley Thomas Director Grant or award · Option to purchase common stock +28,500 28,500
2024-06-05 Malley Thomas Director Grant or award · Option to purchase common stock +26,000 26,000
2023-06-16 Malley Thomas Director Purchase +50,000 $11.50 $575K 139,557
2023-05-31 Malley Thomas Director Grant or award · Option to purchase common stock +26,000 26,000
2022-06-21 Malley Thomas Director Grant or award · Option to purchase common stock +23,000 23,000
2021-06-22 Malley Thomas Director Grant or award · Option to purchase common stock +23,000 23,000
2020-06-24 Malley Thomas Director Grant or award · Option to purchase common stock +23,000 23,000
2019-06-25 Malley Thomas Director Grant or award · Option to purchase common stock +13,000 13,000
2018-06-07 Malley Thomas Director Grant or award · Option to purchase common stock +13,000 13,000

Page 1 of 1 · 12 trades